PHASE 1 MOLECULAR TOXICOLOGY I has a total of 21 patent applications. Its first patent ever was published in 2000. It filed its patents most often in EPO (European Patent Office), Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, computer technology and measurement are NOVOMICS CO LTD, LO YUK MING DENNIS and ARIOSA DIAGNOSTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | Australia | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 5 | |
#4 | Canada | 4 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Computer technology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Bioinformatics | |
#3 | Peptides | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Sankar Usha | 12 |
#2 | Kier Larry | 12 |
#3 | Nolan Timothy D | 12 |
#4 | Derbel Maher | 11 |
#5 | Farr Spencer B | 7 |
#6 | Hicken Samuel H | 4 |
#7 | Farris Georgia | 4 |
#8 | Pickett Gavin G | 3 |
#9 | Neft Robin E | 2 |
#10 | Kier Larry D | 2 |
Publication | Filing date | Title |
---|---|---|
AU2003241418A8 | Liver inflammation predictive genes | |
WO03085083A2 | Liver necrosis predictive genes | |
CA2477688A1 | Kidney toxicity predictive genes | |
AU2002323286A1 | Human toxicologically relevant genes and arrays | |
AU2002258387A1 | Rat toxicologically relevant genes and uses thereof | |
US7091033B2 | Array of toxicologically relevant canine genes and uses thereof | |
WO0047761A2 | High-throughput toxicological testing using cultured organisms and cells |